Liraglutide for Diabetes: Evidence and Outcomes

Evidence on outcomes studied for Liraglutide

Evidence related to liraglutide and liraglutide-containing intervention regimens in diabetes studies.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

12
Studies
53
Evidence Pairs
Moderate Evidence
Evidence Strength: 60/100

Evidence summary for AI and search

Among 12 indexed studies and 3 interventions, the strongest signals are summarized from deterministic graph patterns. Body weight appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Dediabetes summarizes indexed research evidence for education and discovery. This content is not medical advice and should not replace guidance from a qualified clinician.

Supporting Studies

12

Research documents analyzed

Evidence Pairs

53

Intervention-outcome relationships

Latest Publication

May 2026
Powered by the Dediabetes Evidence Intelligence™ framework

Evidence Snapshot

Qualitative overview of the evidence landscape

Moderate Confidence

Based on 12 studies, moderate evidence suggests Body weight, BMI, HbA1c are the strongest-supported outcomes for liraglutide.

Evidence Intelligence™

Evidence Snapshot

A structured summary of where the evidence is strongest, mixed, or still emerging.

View all supporting studies

Evidence at a Glance

12
Studies
3
Interventions
51
Outcomes
1
Strong evidence signals
0
Mixed evidence areas
Evidence freshness
May 2026
Latest indexed
Evidence Story

Liraglutide evidence appears to center on Body weight.

Among 12 indexed studies and 3 interventions, the strongest signals are summarized from deterministic graph patterns. Body weight appears to be one of the clearer current evidence signals.

  • Evidence is consistently positive across multiple studies.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Freshness

Latest indexed evidence: May 2026

Key Finding

Evidence is consistently positive across multiple studies.

Interventions with strongest consistent evidence

Strongest consistent evidence

Why it matters

Consistent positive findings are easier to interpret than isolated or mixed results.

Interpretation

Body weight appears to have a consistent beneficial signal in the indexed evidence.

View supporting studies
Evidence basis: 6 evidence pairs - 6 studies

Why this appears here

Strong evidenceConsistent resultsPositive effect signalMultiple RCTsModerate evidenceMultiple studies
Body weight
5 studies
EvidenceScore™
79/100
ConsistencyScore™
100/100
BMI
3 studies
EvidenceScore™
69/100
ConsistencyScore™
100/100

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Gastrointestinal disorders incidence is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Gastrointestinal disorders incidence
All-cause mortality
Gastrointestinal disorders incidence
2 studies
EvidenceScore™
69/100
ConsistencyScore™
45/100

Why this appears here

Mixed Or Conflicting ResultsNeutral Results PresentNegative Results PresentPositive Signal Present
Evidence basis: 3 evidence pairs - 3 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

BMI may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

BMI
HbA1c
BMI
3 studies
EvidenceScore™
69/100
ConsistencyScore™
100/100

Why this appears here

Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength
Evidence basis: 6 evidence pairs - 5 studies
View supporting studies

Practical Questions

Organized using the Dediabetes Evidence Intelligence™ framework.

What outcomes has Liraglutide been studied for?

outcomes studied
Emerging Evidence

Body weight, BMI, and Waist circumference are among the most studied areas in relation to Liraglutide.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 5 studies

  2. 2

    BMI

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 3 studies

  3. 3

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies

Why this answer: This answer is based on 12 supporting studies and existing graph evidence signals.

Limitations

  • Consistency cannot yet be determined.
  • Population details are unavailable.
12 supporting studies11 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Does Liraglutide improve HbA1c?

intervention outcome_effect
Moderate Evidence

Liraglutide appears to improve HbA1c.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies

Why this answer: This answer is based on a small number of supporting studies and should be interpreted cautiously.

Limitations

  • Only a small number of supporting studies are available.
  • Population details are unavailable.
2 supporting studies1 RCT, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Does Liraglutide affect body weight?

intervention outcome_effect
Strong Evidence

Liraglutide may improve Body weight.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 5 studies

Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
5 supporting studies4 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Which outcomes have the strongest evidence for Liraglutide?

evidence strength
Moderate Evidence

Body weight, BMI, and Waist circumference have the strongest available evidence signals for Liraglutide.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 5 studies

  2. 2

    BMI

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 3 studies

  3. 3

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies

Why this answer: This answer is based on 7 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
7 supporting studies6 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Where does Liraglutide need more research?

research gaps
Moderate Evidence

Waist circumference, HbA1c, and Gastrointestinal disorders incidence need more research in relation to Liraglutide.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies

  2. 2

    Waist circumference

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | moderate positive | ConsistencyScore™ Consistent | 2 studies

  3. 3

    Gastrointestinal disorders incidence

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | weak negative | ConsistencyScore™ Mixed | 2 studies

Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
5 supporting studies4 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

How does Liraglutide compare across studied outcomes?

cross outcome_comparison
Moderate Evidence

Body weight, BMI, and Waist circumference have available evidence for Liraglutide, but the comparison requires review of the underlying studies.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Consistent | 5 studies

  2. 2

    BMI

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 3 studies

  3. 3

    HbA1c

    EvidenceScore™ Moderate | EvidenceScore™ 69.0 | strong positive | ConsistencyScore™ Consistent | 2 studies

Why this answer: This answer is based on 7 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
7 supporting studies6 RCTs, 1 meta-analysisLatest publication: May 2026Updated: Jul 2026

Top outcomes affected

Outcome areas reported in the evidence summary.

Rank #1

Body weight

EvidenceScore™
79/100
ConsistencyScore™
Consistent
Direction: moderate positive
Studies: 5
Rank #2

BMI

EvidenceScore™
69/100
ConsistencyScore™
Consistent
Direction: strong positive
Studies: 3
Rank #3

HbA1c

EvidenceScore™
69/100
ConsistencyScore™
Consistent
Direction: strong positive
Studies: 2

Strongest evidence relationships

Key patterns and insights identified across the research landscape

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

Moderate positive signal

Body weight

Across 4 studies, Liraglutide shows a consistent moderate positive signal for Body weight.

4 studies
EvidenceScore™: 79/100
View supporting studies
Strong positive signal

BMI

Across 2 studies, Liraglutide shows a consistent strong positive signal for BMI.

2 studies
EvidenceScore™: 69/100
View supporting studies
Evidence signal

Gastrointestinal disorders incidence

Across 2 studies, Liraglutide shows a evidence signal for Gastrointestinal disorders incidence.

2 studies
EvidenceScore™: 69/100
View supporting studies
Strong positive signal

HbA1c

Across 2 studies, Liraglutide shows a consistent strong positive signal for HbA1c.

2 studies
EvidenceScore™: 69/100
View supporting studies
Moderate positive signal

Waist circumference

Across 2 studies, Liraglutide shows a consistent moderate positive signal for Waist circumference.

2 studies
EvidenceScore™: 69/100
View supporting studies

Studies evaluating Liraglutide

Studies connected to this intervention in the evidence record.

Click outcomes and interventions to filter the archive when links are available.

Related Evidence Topics

Explore related evidence areas connected by shared studies, interventions, or outcomes.

GLP-1 Receptor Agonists

Intervention

Related because they examine similar outcomes

10 shared studies

Explore all Liraglutide evidence

Browse the complete evidence archive for this topic, including interventions, outcomes, and related research.

Explore all Liraglutide evidence

Filter by study type, publication date, effect size, and more to refine your research